Prof. Richard Baum is a world-renowned pioneer of radiomolecular therapies. With his teams, he has treated over 5000 patients suffering from metastatic cancers, in particular neuroendocrine tumors and metastatic prostate cancer. At present, he is also developing radiomolecular therapies targeting the fibroblasts, which are associated with different cancer types, thus enlarging this promising technique to other types of metastatic cancers that are not yet curable with other methods.
This presentation will be given in the frame of the ARIS Conference (Advances in Radioactive Isotope Science) in Avignon, sponsored among others by the Region PACA.